Street Calls of the Week
Nutex Health Inc. (NASDAQ:NUTX), a healthcare company with a market capitalization of $516 million and strong financial health metrics according to InvestingPro, disclosed Monday that a putative securities class action complaint was filed against the company and certain executives in the United States District Court for the Southern District of Texas in Harris County. The complaint, filed Friday, names Nutex Health , its Chairman and Chief Executive Officer, Chief Financial Officer, and President and Director as defendants.
According to the company’s statement, the lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. The allegations in the complaint are based on a recent short seller report. The plaintiff is seeking unspecified damages.
Nutex Health stated it disputes the allegations and intends to defend the lawsuit. The company noted that it is currently unable to predict the outcome of the litigation or estimate any potential financial impact. The filing also states that an adverse ruling could have a material adverse effect on the company’s financial position or results of operations.
This information is based on a statement released in a Form 8-K filing with the Securities and Exchange Commission.
In other recent news, Newtek Health reported substantial growth in its Q2 2025 earnings, with total revenue climbing to $244 million, marking a 220% increase compared to the previous year. The company also noted a significant rise in adjusted EBITDA and cash collections, highlighting its financial strength. Despite facing higher labor and supply costs, Newtek Health’s investments in hospital developments and AI initiatives have contributed to its expansion. These recent developments underscore the company’s strategic focus on growth and innovation. Analysts have yet to provide specific upgrades or downgrades for Newtek Health, but the company’s performance has drawn attention in the investment community. The reported growth figures indicate a strong trajectory for the company’s future operations. Investors will be closely monitoring Newtek Health’s strategic moves and financial results in the coming quarters.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.